Probiotics are increasingly being added to food in order to develop products with health-promoting properties. Particularly, Saccharomyces cereviceae var. boulardii yeast is recently being investigated like a starting-culture for development of functional and probiotic foods. Although the literature is abundant on the beneficial effects of S. boulardii on health, slight information is available on the effects of supplementing this probiotic to food systems. The aim of this paper is to examine the applications of S. boulardii to different food matrices and its implication in food processing (stability, sensorial properties and other technological implications) and the concomitant effects on nutrition and health.
Introduction
The use of bacteria, yeasts and molds in fermented food has been permanent throughout the history of different cultures worldwide. Products such as bread and fermented beverages like beer, wine, the ancient maize-based beverage named chichi and soy sauce; fermented meat products like salami, and an array of dairy products including cheeses, yogurts and kefir, have been frequently consumed by many cultures for more than 4000 years.
Traditionally, and from an economic perspective, yeasts have become the most important micro-organisms which mankind has made use of for processing the most relevant alcoholic beverages and breads. The key of these fermenting processes is the utilization of yeasts, predominantly in their anaerobic phase. Yeast metabolizes primarily hexoses as monosaccharides (glucose, fructose, galactose or mannose) or disaccharides (maltose or sucrose) as their main carbon source (Hatoum et al. 2012) . Furthermore, both biotic and abiotic factors associated with the production of different food matrices, affect the yeast metabolic activity and consequently primary food components (proteins, carbohydrates and lipids). Resulting chemical and biochemical changes also affect rheological, sensorial and nutritional characteristics of fermented foods (Mehta and Kamal-Eldin 2012) . Without belittling the desirable rheological and sensorial characteristics of fermented products, these probiotic yeasts release and modify secondary metabolites which can improve nutraceutical features of food and beverage (Fleet 2007; Ryan et al. 2011) .
The yeast Saccharomyces cerevisiae var. boulardii is known to be a relevant probiotic. In 1984, this yeast was found in Indochinese tropical lychee (Litchi chinensis) and associated as a biotherapeutic agent (Hatoum et al.
intended for use by the general healthy population (Venugopalan et al. 2010) . However, it has not been widely employed for processing functional human foods (Van der Aa K€ uhle et al. 2005) , even though its utilization in animal feed is extensive (Buzatti et al. 2015) .
Among food items which could be fermented with this yeast, the most investigated are dairy products (LourensHattingh and Viljoen 2001; Parrella et al. 2012; Karaolis et al. 2013; Zamora-Vega et al. 2015) , fruit juices and fermented beverages (Fratianni et al. 2013 (Fratianni et al. , 2014 De girmencio glu et al. 2016) , cereals, legumes and their derived products (Heenana et al. 2004; Rekha and Vijayalakshmi 2010; Ryan et al. 2011; Bastos et al. 2014) . However, as mentioned before, the number of publications related to the application of S. boulardii in various food matrices is scarce and focuses on the incorporation of this yeast as probiotic agent.
The aims of this paper were to compile relevant scientific information of the main applications of S. boulardii in processed foods and its influence on the products treated with this yeast in terms of sensory and functional effects. In addition, the paper also aims to explore its possible harmful effects on food products and consumers.
Probiotics implications of S. boulardii in human health
According to the International Scientific Association for Probiotics and Prebiotics, probiotics are defined as 'live micro-organisms that, when administered in adequate amounts, confer a health benefit on the host' (Hill et al. 2014) . It is known that probiotics reduce the colonization of pathogens by keeping the intestinal microbioma, improve the immune system, reducing lactose intolerance symptoms (Parvez et al. 2006) , enhance the growth of beneficial bacteria (Bastos et al. 2014) , and promote the production of enzymes such as lactase and maltase (Karaolis et al. 2013) .
The oral administration of probiotic S. boulardii ( Fig. 1) is especially related to prevention and treatment of gastrointestinal diseases, such as foodborne and traveller 0 s diarrhoeas, irritable bowel syndrome (IBS), colitis and related malaises such as inflammatory bowel (IBD) and Crohn's diseases, adults 0 and children 0 s acute gastroenteritis, HIV-infected chronic diarrhoea caused by Clostridium difficile, Vibrio cholerae, and other pathogenic enterobacteria (Czerucka et al. 2007; Ryan et al. 2011; Łukaszewicz 2012; Buzatti et al. 2015) , and a significant decrease in the intensity of toxocariasis (Profir et al. 2015) . Its efficiency has been documented in several clinical studies (Czerucka et al. 2007; Hatoum et al. 2012; Lobato et al. 2015) . Moreover, probiotic yeasts have been used to alleviate the side effects of treatments against Helicobacter pylori, a gastritis-causing bacteria (Profir et al. 2015) because it is able to inhibit the formation of gastric lymphoid follicles induced by Helicobacter suis infection (Yang et al. 2017) .
The mechanisms of action of S. boulardii in human metabolism are related to antimicrobial properties, trophic action and immune regulation (Berni Canani et al. 2011) . Normally, yeast do not colonize the intestinal tract, and is eliminated after approximately 14 days once its supplementation has been interrupted (Karaolis et al. 2013) . Some mechanisms through which S. boulardii make its therapeutic action is by liberating polyamines that stimulate the reparation of intestinal cells and the synthesis of the colonic mucosae, which increase the generation of short-chain fatty acids and enzymes which hydrolyse several disaccharides (lactase, maltase and sucrase or invertase; Profir et al. 2015) . Saccharomyces boulardii proteases are known to inhibit Toxin A and Toxin B of C. difficile, which are mainly responsible for diarrhoea and colitis (Castagliuolo et al. 1999) .
In addition, this sort of yeast enhances signalling pathways associated with the pro-inflammatory responses such as the inhibition of the nuclear factor-Kappa B (NFjB), and blocks activation of extracellular signal-regulated kinase (ERK1/2) and mitogen-activated protein kinases (Kelesidis and Pothoulakis 2012; Łukaszewicz 2012) . Moreover, S. boulardii regulates the cytokines pro and anti-inflammatory factors (interleukins IL-10, IL-1b, IL-23A, tumour necrosis factor (TNF)-a, IL-12b, interferonc (INF-c), and IL-17A) in the colonized intestinal mucosa (Kelesidis and Pothoulakis 2012; Łukaszewicz 2012) . Moreover, S. boulardii can effectively induce immune response by increasing IgA and IgG levels (Hudson et al. 2016) .
Nevertheless, the security of S. boulardii as biotherapeutic agent has been questioned due to registered cases of fungaemia (Martin et al. 2017) . In fact, S. boulardii has been contraindicated for persons with fragile health and in immunocompromised and critically ill patients (Atici et al. 2017; Roy et al. 2017) , as well as for patients with a central venous catheter in place (Ricci et al. 2017) . However, these authors did not report any fungaemia related to the supplementation of S. boulardii in food.
Saccharomyces boulardii encapsulation strategies as a probiotic agent for food applications As mentioned before, most investigations related to the processing of S. boulardii present in foods and beverages deal with its utilization as probiotic. The encapsulation of S. boulardii, has been widely used to improve its feasibility in different food matrices (Bastos et al. 2014; ZamoraVega et al. 2015) .
Micro-organisms intended to be used for this purpose in food or beverage need to fulfil certain technological criteria. Thus, apart from promoting consumers 0 health, the micro-organisms should not produce harmful effects on a product 0 s shelf-life and/or sensorial properties (Heenana et al. 2004; Bastos et al. 2014) . It needs to be technologically feasible in terms of growth, pH, resistance to salt, enzymatic activity, and it should have good adhesion to the intestinal mucosa (Buzatti et al. 2015) . One relevant consideration is that the probiotic micro-organism should remain viable (10 6 -10 7 CFU per g), during the expected shelf-life of the probiotic food or beverage (WHO/FAO, 2006) . Consequently, processors have to guarantee that the yeast S. boulardii will remain viable after facing the digestive tract conditions and therefore reach the colon where it should proliferate exerting its beneficial probiotic effects (Zamora-Vega et al. 2012 Rodriguez et al. 2017) . However, the Word Gastrointestinal Organization recommends to consume 5 9 10 9 CFU of S. boulardii for certain gastrointestinal disorders (Guarner et al. 2017) .
The cell wall of S. boulardii is thicker in comparison with other yeasts. Some of its probiotic properties which include resistance to stress due to changes in regular and simulated gastrointestinal pH conditions can be explained by these cell wall properties (Hudson et al. 2016 ). In addition, S. boulardii has a great resistance to a body temperature of 37°C (Czerucka et al. 2007 ), exposure to gastric acid and bile (Ivanova et al. 2012) , good adhesion to the gastric wall (Diosma et al. 2014) , and, therefore, high viability (Bastos et al. 2014) .
The encapsulation of S. boulardii before addition to food has been proposed. Zamora-Vega et al. (2012) noticed the encapsulation of yeast with a mixture of alginate, inulin, and mucilage in order to enhance feasibility and favour the development of functional food like cheeses and yogurts. This last technique was used by Rodriguez et al. (2017) to elaborate a functional freezedried yogurt. As expected, the microencapsulation increased the viability of S. boulardii and extended the full benefits of the product compared to product supplemented with free or nonencapsulated yeast.
On this respect, Arslan et al. (2015) proposed the use of gelatin and Arabic gum for S. boulardii microencapsulation. The microencapsulation at higher temperatures resulted in yeast that showed higher resistance to simulated gastric processes. Both encapsulating agents performed adequately when spray-dried at 125°C. Therefore, the encapsulated S. boulardii should be able to replace free cells as probiotic agents in food.
It is important to mention that S. boulardii is registered as a biological agent recommended to be intentionally added to food or feedstuff (QPS -the qualified presumption of safety) as notified by EFSA 5: appropriateness of the taxonomic units notified to EFSA by September 2016 (Ricci et al. 2017) . 
Nutritional and nutraceutical implications of S. boulardii in fermented foods
Micro-organisms which commonly ferment foods are complex communities largely composed of bacteria, yeasts and molds, and constitute themselves an ecosystem which should be analysed as a whole, not separately (Mehta and Kamal-Eldin 2012) . It is critically relevant to study the antagonistic role of micro-organisms with yeast because they compete for available micronutrients and adapt differently to varying pH conditions in the intestinal lumen due to ionic exchange or production of organic acids, high concentrations of ethanol, and existence of different nutraceutical compounds (Hatoum et al. 2012) . Fermentation reactions are commonly related to the activity of multiple enzymes produced by the different cultures which work cooperatively or sequentially (Kamal-Eldin 2012) .
Yeasts are well known to oxidize and ferment simple sugars into CO 2 , H 2 O and ethanol. However, they are also capable of transforming peptides, amino acids and sugars into flavourful compounds such as higher fusel alcohols, organic acids, aldehydes, ketones, esters, terpenes and sulphur lactones (Carballo 2012) .
The improvement of food for health purposes, especially for treatment of bowel disease, is not limited to supplementation of probiotics. Recently, probiotics, prebiotics, symbiotic, fibre and herbal medicinal products are at the same time both current and promising therapeutic approaches (Curr o et al. 2017) . There is an intense activity in the development of functional foods supplemented with these bioactive compounds or nutraceuticals (Champagne et al. 2005) . In this way, S. boulardii might not necessarily be considered only as probiotic but also as key element for the generation of bioactives such as amino butyric gamma acid (a nonprotein amino acid) and B-vitamins such as thiamine, riboflavin, biotin and pyridoxine. However, the yeast fermentation process may diminish concentrations of pantothenic acid (KamalEldin 2012). Saccharomyces boulardii influences the synthesis of active phytochemicals such as isoflavones (Rekha and Vijayalakshmi 2010) , and phenols (De girmencio glu et al. 2016), thus increasing the antioxidant capacity of the products. Additionally, its utilization enhances bioavailability of essential minerals and B-vitamins (Chandrasekar-Rajendran et al. 2017) and diminishes concentration of antinutrients like phytates. Regarding the improvement of the nutritional value observed in food treated with S. boulardii, it is known that this yeast catalyses the breakdown of dietary phytates resulting in a significant improvement of essential mineral bioavailability. Additionally, the yeast promotes the biofortification of folates and other relevant B-vitamins (Fleet 2007; Rekha and Vijayalakshmi 2010; Ryan et al. 2011; Chandrasekar-Rajendran et al. 2017) .
The extracellular fraction of the S. boulardii cultures was found to be rich in polyphenolic metabolites: vanillic acid, cinnamic acid, phenyl ethyl alcohol (rose oil), erythromycin, amphetamine and vitamin B6. The antioxidant capacity of this strain was established by Datta et al. (2017) who compared S. cerevisiae and S. boulardii (NCYC -3264) in terms of their responses to different stress conditions, antioxidant capacity, and the production of therapeutically important secondary metabolites. Saccharomyces boulardii showed no significant difference in growth patterns but greater stress tolerance compared to S. cerevisiae. Additionally, S. boulardii comparatively produced six-to 10-fold greater antioxidant potential, and 70-and 20-fold higher total phenolics and flavonoids in the extracellular fraction. Sindhu and Khetarpaul (2003) described the nutritional improvement of an indigenous food containing rice (Oryza sativa) flour, whey, green grass seeds and tomato pulp (2 : 1 : 1 : 1 w/w) fermented with a liquid culture of Lactobacillus casei, Lactobacillus plantarum or S. boulardii or with a sequential addition of all these micro-organisms. The capacity of this food to lower serum cholesterol in laboratory mice was assessed. Researchers observed that all fermentations dramatically lowered the contents of phytic acid, polyphenols and trypsin inhibitor activity while significantly improving in vitro digestibility rates of both starch and proteins. Interestingly, the sequential culture fermentations produced better changes as compared to individual culture fermentations. Campbell et al. (2017) researched the enhancement of the nutritional value of sweet potato (Ipomoea batatas) using S. boulardii (ATCC MYA-796). The controlled fermentation with this yeast enhanced protein, crude fibre, neutral detergent fibre, acid detergent fibre, amino acid and fatty acid levels. These authors concluded that S. boulardii-fermented sweet potato has great potential as probiotic-enriched animal feed and/or functional food for human nutrition.
Saccharomyces boulardii in dairy products
Dairy products have been traditionally considered the best carriers for the delivery of probiotics and needless to say these products supply most probiotics to humankind. After dairy products, soybean-based products, such as soymilk, emerged as the most suitable vehicles for supplementation of probiotic cultures (Champagne et al. 2005) . Yeasts are rarely used as starter-cultures compared to LAB. However, different strains of Saccharomyces such as S. burnetii, S. kluveri, S. byanus, S. rosinii, S. cerevisiae and S. boulardii have been naturally isolated from an array of dairy products, including milk, yogurt, cream, dahi, cheese and kefir. The major reason that Saccharomyces forms parts of the secondary flora is that it cannot ferment lactose. Yeasts may develop after LAB have transformed lactose into glucose and galactose, or when the food is intentionally supplemented with sugars (Parrella et al. 2012). Even though yeasts are not capable of growing in milk, it has been demonstrated that S. boulardii is efficient in using fermented yoghurt rich in organic acids, galactose and glucose (Champagne et al. 2005) .
Normally, glucose produced by fermentation of lactose is further transformed into lactic acid. Some yeasts have the capacity to metabolize both lactic acid and other organic acids affecting acidity, thus creating a selective environment for both its growth (Fleet 2007; LourensHattingh and Viljoen 2001) and LAB development. Saccharomyces boulardii survives significantly better at low pH than other strains of S. cerevisiae. For this reason, the yeast present in the microbiota has more potential as probiotic (Lourens-Hattingh and Viljoen 2001). Studies carried out by Parrella et al. (2012) have demonstrated that the cofermentation of LAB and S. boulardii (CNCM I-745, lyo.) in raw, pasteurized or UHT milks, favoured the yeast because it can metabolize lactic fermentation products such as glucose and galactose for growth and at the same time it assures the stability of LAB strains throughout storage. Moreover, these associations improve the antioxidant properties of fermented final products. In this way, the growth of probiotic yeasts in combination with LAB seems to improve the survival of the probiotic bacteria when pH is stabilized. Rekha and Vijayalakshmi (2010) observed that, when soy milk was fermented with different LAB strains and S. boulardii (pharmacologic strain), strong decrease in pH and a fast increase of acidity occurred during the first 24 h in comparison with a later stabilization of these during the rest of fermentation.
This behaviour was previously observed by Karaolis et al. (2013) when a mixture of LAB and S. boulardii was employed for the processing of goat 0 s yogurt. These researchers reported an improvement in their feasibility during fermentation and storage. Interestingly, the final yogurt was more stable and sensorially accepted by panelists. Furthermore, this investigation recommended supplementation with S. boulardii after LAB fermented and coagulated the milk. This strategy yielded yogurts with S. boulardii viable in high amounts throughout 4-weeks of storage. Contrarily when the LAB strains and yeast were added simultaneously to the goat milk, the growth of yeast was not favoured. Lourens-Hattingh and Viljoen (2001) showed that the inoculation of 10 7 -10 8 UFC per g of S. boulardii to unsterilized yogurts or UHT milk did not diminish cell counts after storage at 5°C for 28 days. However, S. boulardii significantly grew in fruit-based yogurts primarily because they contain higher amounts of fermentable sugars, derived from the added fruit. Unfortunately, the yeast produced gas and ethanol which spoiled the product.
These nonencouraging effects were also observed when S. boulardii was added. Heenana et al. (2004) researched the viability and feasibility of different inoculated probiotics in frozen soymilk-based desserts. It was observed that S. boulardii lose 10 more times its feasibility during the first 10 weeks of storage as compared to LAB. A similar trend was observed when the tolerance to bile was determined.
Studies carried out by Zamora-Vega et al. (2015) showed that fresh cheese, due to its acidity, has a greater buffering capacity, oxygen exclusion and fat content, so it can be a better matrix compared to yogurts. Yeast might help to enhance shelf-life and improve nutritional value. The growth of Saccharomyces spp. in cheese might be related to its capacity to use lipids and proteins and to form metabolites different from the ones normally produced by LAB. On the other hand, the encapsulation of S. boulardii before its addition to these products has been proposed by authors as Zamora-Vega et al. (2012) .
Finally, Rekha and Vijayalakshmi (2010) reported that the strategic combination of LAB and S. boulardii during soy milk fermentation has great potential to enrich beverages containing bioactive isoflavones. Moreover, the yeast supplementation significantly diminished antinutrients, such as phytic acid, and increased bioavailability of essential minerals and group B-vitamins including folates. Saccharomyces isolated from kefir has been capable of generating significant amounts of 5-methyltetrahydrofolate (Patring et al. 2006 cited by Kamal-Eldin 2012).
Saccharomyces boulardii in cereal and legume processing
The aim of many cereal or legume processes is to get rid of antinutrients and to stabilize nutrients through enzyme deactivation. Generally, this is achieved through thermal treatments; however, it is well known since ancient times that fermentation is an effective, easy and profitable way to diminish the amounts of antinutrients and to preserve and extend lifespan of foods.
One of the main antinutrients associated with both cereals and legume seeds is phytates. During food processing, phytates can be degraded through either endogenous enzymes or by enzymes produced by yeasts and LAB (Moslehi-Jenabian et al. 2010) . Nutritionally, phytases enhance the bioavailability and absorption or important essential minerals such as iron, zinc, magnesium and phosphorus (Rajkowska et al. 2012) . These positive effects have been related mainly to the supplementation of S. boulardii. Ryan et al. (2011) carried out a stabilization study of rice bran for human use as functional ingredient or dietary supplement through its fermentation with S. boulardii. Researchers were able to observe an enhanced metabolite diversity and showed that extracts of different genotypes affected lymphoma growth differently. These researchers also observed significant differences in bioactivity and normal and malignant lymphocyte growth when nonfermented and S. boulardii-fermented rice brans were compared. The yeast utilized the rice bran as a primary carbon source and enhanced the liberation of key phytochemicals bound through ester links to the fibrous cell walls. The chemopreventive compounds found in rice bran included tocopherols, polyphenols, inositol hexa phosphate (IP6), nonstarch polysaccharides, y-oryzanol and phytosterols.
Cereals-based products and other low-water-activity grains have been proposed as vehicles for the addition of this probiotic yeast. Chandrasekar-Rajendran et al. (2017) showed increased levels of folate and riboflavin in idli batter, consisting of wet-milled rice and black gram (Vigna mungo) fermented with S. boulardii SAA655. Moreover, the microbial starter incorporation did not significantly influence the pH of the idli batter, but enhanced its functional and technological characteristics. Gutierrez-Osnaya et al. (2017) recently analysed functional oligosaccharides in barley malt worts supplemented with S. boulardii. The growth kinetics of this yeast indicated that it is well adapted to the wort and that its enzymes were capable of hydrolysing or converting the mixture of sugars into simpler ones with prebiotic effects.
Other products such as cereal bars have been proposed as carriers of probiotic yeast. Bastos et al. (2014) observed the availability of S. boulardii encapsulated with calcium alginate after 6 weeks of storage and concluded that availability was comparatively inferior to bars supplemented with Lactobacillus acidophilus. However, the yeast did not lose its probiotic property and did not negatively affect the sensory characteristics of the nutritious bar.
Saccharomyces boulardii in beverages
The need for making these beverages 'appetizing' to satisfy the growing demand for functional food, has led researchers to develop fruits, legumes, cereals and soybean fermented with S. boulardii with both pre and probiotic activities. This probiotic yeast, apart from fulfilling the requisite of generating CO 2 and alcohol, showed the capacity of generating bioactive compounds.
Yeast, because of its capacity to transform sugars into alcohol and CO 2 , has been widely used in the processing of fermented beverages. Yeast breaks down glucose and fructose via glycolysis into pyruvic acid, which is later decarboxylated into acetaldehyde and CO 2 . Finally, acetaldehyde is further transformed into alcohol. The whole metabolic process is performed via the activation of a series of enzymes (Carballo 2012) . In this way, the fermentative activity of S. boulardii has been proposed for the elaboration of cereal-based fermented beverages mainly due to its ability to generate high amounts of CO 2 . Casanova et al. (2014) concluded that S. boulardii (ATCC MAY-796) generates higher CO 2 when cultured on YPG (Yeast Peptone Glucose) broth and malt extract as compared to other health-promoting yeasts such as Saccharomyces pastorianus, Kazachstania exigua and Kl. lactis.
In addition, S. boulardii is capable of generating bioactive compounds in functional fermented beverages. A study carried out by De girmencio glu et al. (2016) , concluded that vegetable juices (radish, carrots and beets) fermented with S. cereviseae and S. boulardii were rich in phenols and exerted high antioxidant capacity. Particularly, that beet juice had the greatest bio accessibility and antioxidant activity.
Other sorts of fruit juices have been supplemented with S. boulardii in order to generate probiotic beverages. Fratianni et al. (2013) observed that S. boulardii kept its availability during 56 days at 4°C (expected shelf-life) in tomato juice and that the juice resisted control tests when tested under simulating bowel conditions. Likewise, later the same research group (Fratianni et al. 2014 ) assessed the availability of probiotic berry juice supplemented with S. boulardii (no specific stain) yeast encapsulated with an alginate-xanthan-inulin matrix. In this study, a better feasibility of the fermented juice and bowel simulation performance were observed. Researchers concluded that the proposed encapsulation scheme enhanced both juice fermentation and the preservation of its feasibility in gastric conditions.
In a recent publication, Gallo et al. (2014) proposed the encapsulation of S. boulardii in alginate pearls for the production of apple pieces. Pearls were applied as a reusable biocatalyst for fermenting grape juice. As pearls were sequentially used, they expelled significant amounts of viable yeast cells which produced greater concentrations of ethanol. Yeast immobilized in apple pieces showed high performance in grape juice after several reuses and the yeast was found at concentrations over 7Á3-7Á8 log UFC per ml after 24 h of fermentation. Authors concluded that the encapsulated yeast yielded higher ethanol concentrations in fermented grape juice.
These studies clearly demonstrated that juice supplemented with probiotics is challenging from the nutritional, processing and nutraceutical or health-promoting viewpoints. However, the supplementation of 10 3 UFC per g or higher can cause off-flavour and texture to fermented food mainly due to alcoholic fermentation. Saccharomyces boulardii continues to be an under exploited culture as food additive (Van der Aa K€ uhle et al. 2005) .
Saccharomyces boulardii in biological control in food
Da showed an effective biological control capacity of probiotic strains of S. boulardii (CNCM-17) because they significantly reduced spore production of Aspergillus parasiticus in peanuts. It was determined that all probiotics inhibited sporulation of the molds, obtaining better results with living cells. The presence of probiotics altered the colour of the A. parasiticus colony but not the spore morphology. A significant reduction in the aflatoxin production was obtained with the yeast strains, but better results were obtained when S. boulardii and Lactobacillus delbrueckii acted together. Probiotics remained viable in peanut grains even after 300 days of storage.
In other study, Heling et al. (2017) analysed the potential use of S. boulardii in the biological control of Colletotrichum musae in organic bananas. Bananas previously sanitized and treated with cells of S. cerevisiae or S. boulardii was inoculated with C. musae at three spots per fruit. Treatments with S. cerevisiae or S. boulardii reduced by 48 and 35% the incidence of the anthracnose disease at concentrations of 5Á5 and 6Á3 g l À1 , respectively. The authors concluded that these yeasts are potential agents for the biological control of this relevant pathogen (Heling et al. 2017) .
Conclusions
Saccharomyces boulardii improves its functionality and the functionality of accompanying bacteria in fermented foods. This effect is related to the capacity of S. boulardii strains to stabilize pH and acidity of food matrices for prolonged periods of time, so as to permit an ideal environment for bacterial growth. Also, there is evidence that it is quite stable during food storage conditions. However, in some cases it may affect the sensorial characteristics of finished food products. Besides, it has an interesting beneficial effect on the nutritional value of foods since they synthesize folates and eliminate phytates and other antinutrients. In addition, S. boulardii generates several metabolites or nutraceuticals known to exert positive health benefits. Despite the criteria of S. boulardii analysed in this paper, it is necessary to carry out further research to determine accurately the potential use of this yeast in specific functional food with proper customer 0 s acceptance.
